Genomics Related Content

Implementing personalising genome sequencing and tailoring analysis to each individual patient could double diagnostic rates of rare diseases.

We speak to Professor Ute Deichmann, Director of the Jacques Loeb Centre for the History and Philosophy of the Life Sciences at the Ben-Gurion University of the Negev, about the history of science.

Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.

Scientists say that 16 specific genes are potentially responsible for why some people become ICU COVID cases, and others don't.

Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.

The study, published in The Lancet Digital Health, found that deep learning tech had an average accuracy of 88% when it came to diagnosing genetic syndromes.

A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".

A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.

Novacyt Group, discusses the evolution of testing and sequencing during COVID-19 with a panel of distinguished speakers.

The NSF’s Division of Integrative Organismal Systems, within the Directorate for Biological Sciences, discusses how their work determining phenotype from genotype is fighting food insecurity.

Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.

Here, Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group argues that single-cell genomics empowers clinical strategies for COVID-19.

Professors Darren Griffin and Mike Bruford (Universities of Kent and Cardiff) discuss what is meant by a “whole genome sequence” and how it is revolutionising conservation efforts.

Dr Craig Titmus, Partner and UK and European Patent Attorney at intellectual property firm, Mathys & Squire, turns the spotlight on genomics and public health from a patent attorney’s perspective.

Peter Goodhand and Angela Page from Global Alliance for Genomics and Health, explain their thoughts on enabling a global learning health system through genomic standards.

David S. Wishart discusses metabolomics, how the field is breaking into biochemical mysteries and the “dark metabolome”.

Ewan Birney, Director of EMBL’s European Bioinformatics Institute (EMBL-EBI), reveals how genomics could improve healthcare and pave the way to precision medicine.

Dr Katie Finch discusses with Professors Darren Griffin and Alan Thornhill her personal journey involving genetic testing of her son Brandon.

Results from NASA's landmark Twins Study reveals interesting, surprising and reassuring data about how one human body in space adapted to, then recovered from, that extreme environment.